OncologyPro

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

OncologyPro
Jul 28, 2024, 10:33 | Blog
Breaking Science in Gastrointestinal Cancers with Giovanni Randon - ESMO
ESMO - European Society for Medical Oncology shared on LinkedIn: "For ESMO members: Breaking Science…
Jul 25, 2024, 00:18 | Blog
Breaking Science in Gastrointestinal Cancers with Kohei Shitara - ESMO
ESMO (European Society for Medical Oncology) shared on LinkedIn: "For ESMO members: Breaking Science in Gastrointestinal…
Jul 19, 2024, 08:42 | Blog
Breaking Science in Gastrointestinal Cancers with Maximiliano Gelli - ESMO
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "For ESMO members:…
Jul 17, 2024, 09:44 | Societies
7 interviews summarizing study results from ESMOGI24
The European Society for Medical Oncology (ESMO) shared on LinkedIn: "The Breaking Science in Gastrointestinal…
Jul 3, 2024, 12:06 | Insight
Guillermo Villacampa presents the HER2DX assay and its impact on survival outcomes
ESMO shared on LinkedIn: "For ESMO members: Breaking Science in breast cancer. Guillermo Villacampa presents…
Jun 29, 2024, 03:18 | Blog
Peter Schmid's findings on atezolizumab and sacituzumab govitecan for advanced TNBC - ESMO
ESMO shared a post on LinkedIn: “For ESMO members: Breaking Science in Breast Cancer. Peter Schmid…
Jun 29, 2024, 02:57 | Blog
Komal Jhaveri on antibody-drug conjugates in metastatic breast cancer - ESMO
ESMO shared a post on LinkedIn: “For European Society for Medical Oncology (ESMO) members: Breaking Science…
Jun 28, 2024, 11:43 | Blog
Mafalda Oliveira discusses ESR1m ctDNA in MBC patients treated by camizestrant
The European Society for Medical Oncology (ESMO) posted on LinkedIn: “For ESMO members: Breaking Science…
Jun 28, 2024, 11:02 | Blog
Severine Guiu explains triple combination therapy for ER+/HER2- ABC with HRR deficiency or MSI - The European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) posted on LinkedIn:     . “For ESMO members:…
Jun 23, 2024, 10:53 | Blog
Breaking Science in Breast Cancer with Hope Rugo - ESMO
ESMO shared a post on LinkedIn: "For ESMO members: Breaking Science in Breast Cancer. Hope Rugo…
Jun 23, 2024, 02:25 | Blog
Elisa Agostinetto: Important data for patients who desire pregnancy after a diagnosis of breast cancer
Elisa Agostinetto shared a post by ESMO on X/Twitter: "Are assisted reproductive techniques safe in…
Jun 21, 2024, 14:02 | Blog
Breaking Science in Breast Cancer with Matteo Lambertini - ESMO
ESMO shared on X/Twitter: "For ESMO members: Breaking Science in Breast Cancer. Matteo Lambertini discusses…
May 12, 2024, 12:13 | Insight
Herbert Loong: 6 versus 3 years of adjuvant imatinib in high risk GISTs by Jean-Yves Blay et al.
Herbert Loong shared on LinkedIn: “Congrats Jean-Yves Blay and colleagues of French Sarcoma Group for completing…
All: 13 Posts: 1 - 100
Special Coverage